These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [A clinical study of testicular tumors]. Matsuki H; Ozono S; Arai K; Saka M; Cho M; Nakagawa Y; Kaneko Y; Yoshida K; Okamoto S; Maruyama Y Hinyokika Kiyo; 1988 Oct; 34(10):1757-65. PubMed ID: 2854363 [TBL] [Abstract][Full Text] [Related]
44. Management trends for men with early-stage nonseminomatous germ cell tumors of the testicle: An analysis of the National Cancer Database. Weiner AB; Pearce SM; Eggener SE Cancer; 2017 Jan; 123(2):245-252. PubMed ID: 27626903 [TBL] [Abstract][Full Text] [Related]
45. Discordance of retroperitoneal and thoracic histologic findings in patients with metastatic germ cell tumors at postchemotherapy residual tumor resection. Che Y; Wöltjen C; Lusch A; Winter C; Trainer S; Schirren M; Sponholz S; Knoefel WT; Albers P; Hiester A World J Surg Oncol; 2024 Jul; 22(1):185. PubMed ID: 39020389 [TBL] [Abstract][Full Text] [Related]
46. Adjuvant chemotherapy after orchiectomy in high-risk patients with clinical stage I non-seminomatous testicular cancer. Studer UE; Fey MF; Calderoni A; Kraft R; Mazzucchelli L; Sonntag RW Eur Urol; 1993; 23(4):444-9. PubMed ID: 7687549 [TBL] [Abstract][Full Text] [Related]
47. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma. Carver BS; Shayegan B; Serio A; Motzer RJ; Bosl GJ; Sheinfeld J J Clin Oncol; 2007 Mar; 25(9):1033-7. PubMed ID: 17261854 [TBL] [Abstract][Full Text] [Related]
48. The management of non-seminomatous germ-cell tumours patients with viable malignancy at the time of RPLND. Huddart RA Ann Oncol; 2008 Feb; 19(2):203-4. PubMed ID: 18245130 [No Abstract] [Full Text] [Related]
49. Testicular germ cell tumors in boys <10 years: results of the protocol MAHO 98 in respect to surgery and watch & wait strategy. Göbel U; Haas R; Calaminus G; Botorek P; Schmidt P; Teske C; Schönberger S; Schneider DT; Harms D Klin Padiatr; 2013 Nov; 225(6):296-302. PubMed ID: 24158884 [TBL] [Abstract][Full Text] [Related]
50. Long-term clinical outcome in patients with stage-I nonseminomatous germ cell cancer. A critical review of own treatment modalities in a retrospective study. Seseke S; Bierwirth S; Strauss A; Ringert RH; Seseke F Int Braz J Urol; 2008; 34(6):715-22; discussion 723-4. PubMed ID: 19111076 [TBL] [Abstract][Full Text] [Related]
51. Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer. Pearce SM; Golan S; Gorin MA; Luckenbaugh AN; Williams SB; Ward JF; Montgomery JS; Hafez KS; Weizer AZ; Pierorazio PM; Allaf ME; Eggener SE Eur Urol; 2017 Mar; 71(3):476-482. PubMed ID: 27234998 [TBL] [Abstract][Full Text] [Related]
52. Distribution of retroperitoneal lymph node metastases in patients with non-seminomatous testicular cancer in clinical stage I. Fosså SD; Ous S; Stenwig AE; Lien HH; Aass N; Kaalhus O Eur Urol; 1990; 17(2):107-12. PubMed ID: 2155789 [TBL] [Abstract][Full Text] [Related]
53. Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection. Djaladat H; Nichols C; Daneshmand S Ann Surg Oncol; 2012 Jul; 19(7):2388-93. PubMed ID: 22395993 [TBL] [Abstract][Full Text] [Related]
54. Brain metastasis from non-seminomatous germ cell tumors of the testis: indications for aggressive treatment. Salvati M; Piccirilli M; Raco A; Santoro A; Frati R; Lenzi J; Lanzetta G; Agrillo A; Frati A Neurosurg Rev; 2006 Apr; 29(2):130-7. PubMed ID: 16328533 [TBL] [Abstract][Full Text] [Related]
55. Management of Stage I Nonseminomatous Germ Cell Tumors. Kovac E; Stephenson AJ Urol Clin North Am; 2015 Aug; 42(3):299-310. PubMed ID: 26216817 [TBL] [Abstract][Full Text] [Related]
56. Primary mediastinal germ cell tumours with high prevalence of somatic malignancy: An experience from a single tertiary care oncology centre. Beg A; Kumar R; Sahay A; Janu A; Joshi A; Noronha V; Prabhash K; Karimundackal G; Jiwnani S; Agarwal JP; Pramesh CS Ann Diagn Pathol; 2021 Aug; 53():151763. PubMed ID: 34111707 [TBL] [Abstract][Full Text] [Related]
57. Modified retroperitoneal lymph node dissection for post-chemotherapy residual tumour: a long-term update. Cho JS; Kaimakliotis HZ; Cary C; Masterson TA; Beck S; Foster R BJU Int; 2017 Jul; 120(1):104-108. PubMed ID: 28296054 [TBL] [Abstract][Full Text] [Related]
58. A case of spermatic cord teratoma in low-stage testicular cancer managed by surveillance. Subramanian VS; Gilligan T; Klein EA Nat Clin Pract Urol; 2008 Apr; 5(4):220-3. PubMed ID: 18268549 [TBL] [Abstract][Full Text] [Related]
59. [Treatment of patients with retroperitoneal metastases of nonseminoma tumors of the testis]. Matveev BP; Figurin KM Vopr Onkol; 1988; 34(12):1493-7. PubMed ID: 2464238 [TBL] [Abstract][Full Text] [Related]